跳至主要内容
临床试验/ITMCTR2000003075
ITMCTR2000003075尚未招募1 期

Multicenter prospective randomized controlled trial for Dong-Tian Chang-Chun Ointment in the treatment of stable COPD patients

Zhongshan Hospital Affiliated Fudan University ; Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine0 个研究点开始时间: 待定最近更新:

试验速览

阶段
1 期
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional study

入排标准

年龄范围
40 至 75(—)
性别
All

入选标准

  • 1. Patients who meet the western medicine diagnosis, classification, and stage diagnosis are included patients;
  • 2. History of 1 to 3 acute exacerbations in the past 12 months;
  • 3. Aged 40 to 80 years;
  • 4. The syndrome differentiation of TCM belongs to the syndrome of deficiency of lung qi, deficiency of lung and spleen, deficiency of lung and kidney, and deficiency of both lung and kidney;
  • 5. Voluntarily receive treatment and sign the informed consent.

排除标准

  • 1. Those who do not meet the above-mentioned western medical diagnosis, staging diagnosis and traditional Chinese medicine diagnosis standards;
  • 2. Examination confirms chronic cough caused by tuberculosis, fungi, tumors, irritating gas allergies and other factors;
  • 3. Patients with other respiratory diseases that can cause asthma or dyspnea;
  • 4. pregnant or lactating women, allergic to Symbio 9ug / 320ug and Dongtian Changchun cream;
  • 5. Patients with severe primary diseases such as cardiovascular, liver, kidney and hematopoietic system, and mental illness;
  • 6. Concurrent severe heart dysfunction;
  • 7. Contains factors that affect the observation of efficacy;
  • 8. Those who do not meet the inclusion criteria, fail to use the drug as prescribed, cannot determine the efficacy or incomplete data, etc., which affect the efficacy or safety judgment;
  • 9. Those who are participating in other clinical trials within 1 month before enrollment;
  • 10. Patients with diabetes.

研究者

发起方
Zhongshan Hospital Affiliated Fudan University ; Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine

相似试验

招募中
4 期
Multicenter prospective randomized controlled trial of Vonoprazan and Esomeprazole for reflux esophagitisReflux esophagitisGERDK210
JPRN-jRCTs031200417Matsumura Tomoaki120
已完成
不适用
Multicenter randomized controlled prospective trial in peripheral blood stem cell harvest (PBSCH)Hematological malignancies
JPRN-UMIN000012095Japan Society of Blood Transfusion and Cell Therapy200
已完成
不适用
Prospective, multicenter randomized controlled trial of the self-assembling hemostatic gel PuraStat to prevent delayed bleeding after endoscopicresectionsK63.5K31.7Polyp of colonPolyp of stomach and duodenum
DRKS00028119Asklepios Kliniken Hamburg GmbH Vertreten durch ASKLEPIOS proresearch Lohmühlenstraße 5 Haus J-D20099248
尚未招募
3 期
A multicenter prospective randomized controlled trial: Comparison generic alginate Vs original alginate for symptoms controlled in the non-proton pump inhibitors responder GERDIn patients with gastroesophageal reflux disease, despite taking proton pump inhibitors But only 25.7% of symptoms could be controlled in 7 days and only 35.9% of GERD patients were found to have no heartburn symptoms over 28 days. Patients with GERD are chronic and affect their quality of life worse compared to normal people. which often affects sleep decreased vitality more pain in the body impaired sexual feelings and more anxiety.GERD
TCTR20230119007Dr. Kawin Tangvoraphonkchai162
尚未招募
Unknown
A multicenter prospective randomized controlled trial evaluating the usefulness of a real-time colonoscopy diagnostic support systemColorectal Neoplasms
JPRN-UMIN000051437Toho University Oomori hospital620